Massachusetts General Hospital

5/20/13: Genetic diversity within tumors predicts outcome in head and neck cancer A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer.

5/15/13: Study finds disagreement on the role of primary care nurse practitioners A New England Journal of Medicine study finds that, while primary care physicians and nurse practitioners agree that nurse practitioners "should be able to practice to the full extent of their education and training," they significantly disagree about some proposed changes to the scope of nurse practitioners' responsibilities.

5/14/13: Treatment with two osteoporosis drugs better at increasing bone density than single-drug therapy A combination of two FDA-approved osteoporosis drugs with different mechanisms of action was found to increase bone density better than treatment with either drug alone in a small clinical trial.

5/13/13: Massachusetts General Hospital Receives Highest Nursing Credential With Prestigious Magnet® Recognition … Again The Massachusetts General Hospital has again attained Magnet® recognition as part of the American Nurses Credentialing Center’s Magnet Recognition Program®. This voluntary credentialing program recognizes excellence in nursing and is the highest honor an organization can receive for professional nursing practice.

5/08/13: Mass. General, Duke study identifies two genes that combine to cause rare syndrome Researchers from MGH and Duke University have identified genetic mutations that appear to underlie a rare but devastating syndrome combining reproductive failure with cerebellar ataxia – a lack of muscle coordination – and dementia.